Investigational Site Number : 6162407

Krakow, Lesser Poland Voivodeship 30-510

1 studies enrolling now · 1 studies all time

What they study most

Dermatitis Atopic

Studies at this site

• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials — Enrolling by invitation